Lehrnbecher, T;
Phillips, R;
Alexander, S;
Alvaro, F;
Carlesse, F;
Fisher, B;
Hakim, H;
Santolaya, M;
Castagnola, E;
Davis, B. L;
Dupuis, L. L;
Gibson, F;
Groll, A. H;
Gaur, A;
Gupta, A;
Kebudi, R;
Petrilli, S. L;
Steinbach, W. J;
Villarroel, M;
Zaoutis, T Sung.
To develop an evidence-based guideline for the empiric management of pediatric fever and neutropenia (FN). The International Pediatric Fever and Neutropenia Guideline Panel is a multidisciplinary and multinational group composed of experts in pediatric oncology and infectious disease as well as a patient...
This guideline covers assessing and managing urinary incontinence in children, young people and adults with neurological disease. It aims to improve care by recommending specific treatments based on what symptoms and neurological conditions people have....
This guideline covers diagnosing and managing peripheral arterial disease (PAD) in people aged 18 and over. Rapid changes in diagnostic methods, endovascular treatments and vascular services associated with new specialties in surgery and interventional radiology have resulted in considerable uncertainty ...
The guideline covers diagnosing, treating and managing epilepsy and seizures in children, young people and adults in primary and secondary care. It offers best practice advice on managing epilepsy to improve health outcomes so that people with epilepsy can fully participate in daily life....
Elaborar una guía de practica clínica (GPC) para orientar a los profesionales sanitarios en la toma de decisiones y disminuir la variabilidad en la atención a las personas con Esclerosis múltiple (EM). Proporcionar información útil para los pacientes, familiares y cuidadores que les permita conocer...
Esclerosis Múltiple/terapia,
Esclerosis Múltiple/diagnóstico por imagen,
Esclerosis Múltiple/tratamiento farmacológico,
Espectroscopía de Resonancia Magnética/métodos,
Interferón beta/uso terapéutico,
Acetato de Glatiramer/uso terapéutico,
Azatioprina/uso terapéutico,
Natalizumab/uso terapéutico,
Clorhidrato de Fingolimod/uso terapéutico,
Mitoxantrona/uso terapéutico,
Metotrexato/uso terapéutico,
Ciclofosfamida/uso terapéutico,
Trasplante de Células Madre Hematopoyéticas,
Corticoesteroides/uso terapéutico
Postpartum haemorrhage (PPH) is a major cause of mortality, morbidity and long term disability related to pregnancy and childbirth. Effective interventions to prevent and treat PPH exist and can largely reduce the burden of this life-threatening condition. Given the availability of new scientific evidenc...
Globally, about one quarter of all neonatal deaths are caused by birth asphyxia. In this document, birth asphyxia is defined simply as the failure to initiate and sustain breathing at birth. Effective resuscitation at birth can prevent a large proportion of these deaths. The need for clinical guidelines ...
Objetivo general: generar recomendaciones basadas en la mejor evidencia disponible acerca del manejo de personas con tumores primarios del sistema nervioso central o que hayan sido tratados por ello. Objetivos específicos: personas con tumores primarios del sistema nervioso central o que hayan sido trat...
